arrow
R

Rodrigo de Holanda Mendonça

faculdade de medicina
H指数:13
被引数:762

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neurological symptoms and physical exam findings 6–11 months post-COVID-19: a cohort study

神经症状和体格检查结果:COVID-19后6-11个月的队列研究

2026-01-020
OAAI
Safety and tolerability of onasemnogene abeparvovec for patients with spinal muscular atrophy weighing ≤17 kg and ≤24 months old from OFELIA, a phase 4, open-label, multicenter, non-randomised, interventional study

来自OFELIA(一项第4期、开放标签、多中心、非随机化、干预性研究)的数据显示,onasemnogene abeparvovec在体重≤17 kg且年龄≤24个月的脊髓性肌萎缩症患儿中的安全性与耐受性。

2025-07-280
PRE
Thrombotic microangiopathy following gene therapy for 5q-spinal muscular atrophy

基因疗法治疗5q-脊髓性肌萎缩症后的血栓性微血管病

2025-06-190
PRE
Clinical and molecular spectrum of TK2-deficiency: a large Brazilian cohort

TK2-deficiency的临床和分子谱: 一个大型巴西队列

2025-03-150
OAAI
The Location of Disease-Causing DES Variants Determines the Severity of Phenotype and the Morphology of Sarcoplasmic Aggregates
2022-07-283
PRE
Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophy
2020-10-0535
OAAI
Clinical and molecular findings in a cohort of ANO5-related myopathy
2019-06-1128
OAAI